{
  "_id": "4b76d2eecaa9ff0ca517ed5b2242e7e4b478a9e53ef177cb5909d62478f06199",
  "feed": "wall-street-journal",
  "title": "Merck Lifts Outlook After Quarterly Sales Rise 14%; Pharmaceutical company says top line boosted by oncology drugs, vaccines",
  "text": "<p>Merck &amp; Co. raised its revenue outlook after posting a 14% rise in third-quarter sales on growing demand for its oncology treatments and vaccines.</p><p>The pharmaceutical giant on Thursday said sales climbed to $15 billion in the quarter ended Sept. 30, ahead of market expectations of nearly $14.1 billion, according to FactSet.</p><p>The company said revenue for its key cancer treatment Keytruda and for its human papilloma virus vaccines Gardasil and Gardasil 9, increased 20% and 15% in the period, respectively, boosted by growth in the U.S. and Chinese markets.</p><p>Excluding the impact of a stronger dollar, sales for Keytruda and Gardasil—Merck's top-selling drugs and vaccines—jumped 26% and 20%, respectively.</p><p>However, U.S. sales for its Type 2 diabetes drug, known under the brands of Januvia and Janumet, fell 15% as generic competitors grew, the company said.</p><p>Given current levels of demand, Merck expects to end the year with worldwide sales between $58.5 billion and $59 billion, up to 21% growth year over year. The company's previous guidance topped out at $58.5 billion.</p><p>For the third quarter, Merck's net income came to $3.25 billion, or $1.28 a share, compared with $4.57 billion, or $1.80 a share, a year earlier. Stripping out one-time items, Merck said adjusted earnings were $1.78 a share. Analysts recently polled by FactSet expected adjusted per-share earnings of $1.85.</p><p>Merck shares were up 1.4% Thursday to $99.74.</p><p>Write to Sabela Ojea at sabela.ojea@wsj.com</p><p>Merck Lifts Outlook After Quarterly Sales Rise 14%</p>",
  "published": "2022-10-27T20:44:00.000Z",
  "tags": [
    {
      "id": "US58933Y1055",
      "nexusId": "10042334",
      "name": "Merck & Co., Inc.",
      "offsets": [
        {
          "start": 1383,
          "end": 1388
        },
        {
          "start": 891,
          "end": 896
        },
        {
          "start": 0,
          "end": 11
        },
        {
          "start": 1098,
          "end": 1103
        },
        {
          "start": 0,
          "end": 5
        },
        {
          "start": 1473,
          "end": 1478
        },
        {
          "start": 1251,
          "end": 1256
        }
      ]
    }
  ]
}